Efgartigimod as Fast-Acting Rescue Therapy in Very Late-Onset Myasthenia Gravis
Abstract Myasthenic crisis (MC) is a potentially fatal complication of myasthenia gravis (MG), often requiring intensive care and rescue therapies such as intravenous immunoglobulin (IVIG) and corticosteroids. Efgartigimod, a neonatal Fc receptor (FcRn) antagonist, offers a novel approach by selecti...
Salvato in:
| Autori principali: | , , , , |
|---|---|
| Natura: | Artigo |
| Lingua: | Inglês |
| Pubblicazione: |
Adis, Springer Healthcare
2025-11-01
|
| Serie: | Neurology and Therapy |
| Soggetti: | |
| Accesso online: | https://doi.org/10.1007/s40120-025-00857-0 |
| Tags: |
Nessun Tag, puoi essere il primo ad aggiungerne!!
|